These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27755184)

  • 21. Advances in understanding of the innate immune response to human norovirus infection using organoid models.
    Mboko WP; Chhabra P; Valcarce MD; Costantini V; Vinjé J
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35077345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies.
    Frange P; Touzot F; Debré M; Héritier S; Leruez-Ville M; Cros G; Rouzioux C; Blanche S; Fischer A; Avettand-Fenoël V
    J Infect Dis; 2012 Oct; 206(8):1269-74. PubMed ID: 22872736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virology. Leaping the norovirus hurdle.
    Robinson CM; Pfeiffer JK
    Science; 2014 Nov; 346(6210):700-1. PubMed ID: 25378607
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus.
    Echenique IA; Stosor V; Gallon L; Kaufman D; Qi C; Zembower TR
    Transpl Infect Dis; 2016 Feb; 18(1):98-104. PubMed ID: 26460906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.
    Nice TJ; Baldridge MT; McCune BT; Norman JM; Lazear HM; Artyomov M; Diamond MS; Virgin HW
    Science; 2015 Jan; 347(6219):269-73. PubMed ID: 25431489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norovirus interactions with the commensal microbiota.
    Sullender ME; Baldridge MT
    PLoS Pathog; 2018 Sep; 14(9):e1007183. PubMed ID: 30188944
    [No Abstract]   [Full Text] [Related]  

  • 27. Human norovirus transmission and evolution in a changing world.
    de Graaf M; van Beek J; Koopmans MP
    Nat Rev Microbiol; 2016 Jul; 14(7):421-33. PubMed ID: 27211790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling Estimates of Norovirus Disease in Patients with Chronic Medical Conditions.
    Verstraeten T; Jiang B; Weil JG; Lin JH
    PLoS One; 2016; 11(7):e0158822. PubMed ID: 27438335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin.
    Chagla Z; Quirt J; Woodward K; Neary J; Rutherford C
    J Clin Virol; 2013 Sep; 58(1):306-8. PubMed ID: 23850414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer.
    Knoll BM; Lindesmith LC; Yount BL; Baric RS; Marty FM
    Infection; 2016 Aug; 44(4):551-4. PubMed ID: 26825307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    J Immunol Res; 2018; 2018():3487095. PubMed ID: 29682589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro.
    Niendorf S; Klemm U; Mas Marques A; Bock CT; Höhne M
    PLoS One; 2016; 11(6):e0156898. PubMed ID: 27294868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One more step toward understanding the immune response to norovirus.
    Lee BE; Pang XL
    J Infect Dis; 2014 Dec; 210(11):1691-2. PubMed ID: 24970847
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology. Interfering with interferons.
    Wilks J; Golovkina T
    Science; 2015 Jan; 347(6219):233-4. PubMed ID: 25593173
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic norovirus infection in an immunocompromised patient].
    Lambregts MM; Alleman MA; Ruys GJ; Groeneveld PH
    Ned Tijdschr Geneeskd; 2010; 154():A1067. PubMed ID: 20456762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human norovirus infection and the acute serum cytokine response.
    Newman KL; Moe CL; Kirby AE; Flanders WD; Parkos CA; Leon JS
    Clin Exp Immunol; 2015 Nov; 182(2):195-203. PubMed ID: 26178578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norovirus vaccines: Correlates of protection, challenges and limitations.
    Melhem NM
    Hum Vaccin Immunother; 2016 Jul; 12(7):1653-69. PubMed ID: 26836766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort.
    Fiehn C; Miehle N
    Ann Rheum Dis; 2014 Apr; 73(4):786-7. PubMed ID: 24276367
    [No Abstract]   [Full Text] [Related]  

  • 39. Norovirus gastroenteritis, increased understanding and future antiviral options.
    Tan M; Jiang X
    Curr Opin Investig Drugs; 2008 Feb; 9(2):146-51. PubMed ID: 18246517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of serum and fecal levels of interleukin-6 and interleukin-8 in hospitalized children with acute rotavirus and norovirus gastroenteritis.
    Chen SM; Lin CP; Tsai JD; Chao YH; Sheu JN
    Pediatr Neonatol; 2014 Apr; 55(2):120-6. PubMed ID: 23899552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.